Disclosed are cyclic amine compounds and pharmacologically acceptable salts thereof of formula (I) wherein A and B represent a substitutable cyclic hydrocarbon or a substitutable heterocyclyl, and the remaining substituents are as defined in the specification. Also disclosed are pharmaceutical compositions thereof and the use of said compounds for treating or preventing diseases such as hypertension.
